"Healthy Aging through AI"
PROMEDIUS pioneers the most advanced breakthroughs with AI in age-related conditions, including osteoporosis.
| A New Vision for Osteoporosis |
Osteo Signal is the world’s first screening solution that utilizes chest X-ray images to identify patients who may be at risk of osteoporosis. This technology aims to proactively tackle the challenges of osteoporosis by enabling timely identification of potential patients at risk.
Company Details
- Employees
- 20
- Founded
- -
- Address
- 13, Olympic-Ro 35da-Gil, 4f,korea, Republic Of
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- https://promedius.ai
- Keywords
- AI, Image Diagnosis, Chest X-ray, SaMD, Osteoporosis, Opportunistic Screening, Longevity, Aging, Metabolic Diseases, Bone Health.
- HQ
- Seoul, Songpa-gu
Promedius Questions
Promedius's website is https://promedius.ai
Promedius's LinkedIn profile is https://kr.linkedin.com/company/promedius
Promedius has
20 employees.
View email and phone details for 20
employees at Promedius.
Promedius's industry is
Medical Equipment Manufacturing
Promedius's top competitors are
뉴로핏 (Neurophet),
Aitrics,
Lunit Cancer Screening,
Coreline Soft,
Heuron,
Bonescreen,
Mediwhale,
Airs Medical,
Vuno Inc.,
Won & Ha Partners.
Promedius's categories are Medical Equipment Manufacturing
Promedius's founding year is 2019
